Now showing items 1-2 of 2

    • MAO inhibitors and their wider applications: a patent review 

      Carradori, Simone; Petzer, Jacques P.; Secci, Daniela (Taylor & Francis, 2018)
      Introduction: Monoamine oxidase (MAO) inhibitors, after the initial ‘golden age’, are currently used as third-line antidepressants (selective MAO-A inhibitors) or clinically enrolled as co-adjuvants for neurodegenerative ...
    • Novel monoamine oxidase inhibitors: a patent review (2012-2014) 

      Carradori, Simone; Petzer, Jacobus P. (Taylor & Francis, 2015)
      Introduction: Monoamine oxidase (MAO) inhibitors, despite the initial pharmacological interest, are used in clinic for their antidepressant effect and in the management of Parkinson symptoms, due to the established ...